DRDO's ayurvedic drug for leucoderma attracts global buyers
| Saturday | 13th January, 2018
Owing to this, and encouraged by local demand for herbal medicines, the government is also putting out all stops to tab the global market too.
The technology to manufacture the drug has been transferred to Delhi based AIMIL Pharmaceuticals.
Whereas, this is not the case with the herbal-based medicines which works at the root of the disease," said Hemant Pande, a senior DRDO scientist.
Lack of awareness, myths, and the stigma attached to leucoderma are perhaps the most pressing challenges that take a toll on the social and psychological health of patients.
"Allopathic medicines mask the disease and the patient feels that he/she is healed.
Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.
Stay updated with all the Delhi Latest News headlines here. For more exclusive & live news updates from all around India, stay connected with NYOOOZ.